Zentalis Pharmaceuticals Stock Forward View - Accumulation Distribution
| ZNTL Stock | USD 2.43 0.03 1.25% |
Zentalis Stock outlook is based on your current time horizon. Although Zentalis Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Zentalis Pharmaceuticals' systematic risk associated with finding meaningful patterns of Zentalis Pharmaceuticals fundamentals over time.
As of now the rsi of Zentalis Pharmaceuticals' share price is below 20 . This usually means that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.48) | EPS Estimate Current Year (1.94) | EPS Estimate Next Year (1.81) | Wall Street Target Price 5.3125 | EPS Estimate Current Quarter (0.48) |
Using Zentalis Pharmaceuticals hype-based prediction, you can estimate the value of Zentalis Pharmaceuticals Llc from the perspective of Zentalis Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Zentalis Pharmaceuticals using Zentalis Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Zentalis using crowd psychology based on the activity and movement of Zentalis Pharmaceuticals' stock price.
Zentalis Pharmaceuticals Implied Volatility | 1.73 |
Zentalis Pharmaceuticals' implied volatility exposes the market's sentiment of Zentalis Pharmaceuticals Llc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Zentalis Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Zentalis Pharmaceuticals stock will not fluctuate a lot when Zentalis Pharmaceuticals' options are near their expiration.
Zentalis Pharmaceuticals after-hype prediction price | USD 3.0 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Zentalis Pharmaceuticals to cross-verify your projections. Prediction based on Rule 16 of the current Zentalis contract
Based on the Rule 16, the options market is currently suggesting that Zentalis Pharmaceuticals Llc will have an average daily up or down price movement of about 0.11% per day over the life of the 2026-04-17 option contract. With Zentalis Pharmaceuticals trading at USD 2.43, that is roughly USD 0.002627 . If you think that the market is fully incorporating Zentalis Pharmaceuticals' daily price movement you should consider acquiring Zentalis Pharmaceuticals Llc options at the current volatility level of 1.73%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 Zentalis Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Zentalis Pharmaceuticals' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Zentalis Pharmaceuticals' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Zentalis Pharmaceuticals stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Zentalis Pharmaceuticals' open interest, investors have to compare it to Zentalis Pharmaceuticals' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Zentalis Pharmaceuticals is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Zentalis. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Zentalis Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Zentalis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Zentalis using various technical indicators. When you analyze Zentalis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 29057.39 | 27173.65 |
| Check Zentalis Pharmaceuticals Volatility | Backtest Zentalis Pharmaceuticals | Information Ratio |
Zentalis Pharmaceuticals Trading Date Momentum
| On February 11 2026 Zentalis Pharmaceuticals Llc was traded for 2.43 at the closing time. The top price for the day was 2.49 and the lowest listed price was 2.29 . The trading volume for the day was 338.3 K. The trading history from February 11, 2026 had no short-term effect on price fluctuation. The trading date delta against the current closing price is 2.47% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Zentalis Pharmaceuticals to competition |
Other Forecasting Options for Zentalis Pharmaceuticals
For every potential investor in Zentalis, whether a beginner or expert, Zentalis Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Zentalis Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Zentalis. Basic forecasting techniques help filter out the noise by identifying Zentalis Pharmaceuticals' price trends.Zentalis Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Zentalis Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Zentalis Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Zentalis Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Zentalis Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Zentalis Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zentalis Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Zentalis Pharmaceuticals stock market strength indicators, traders can identify Zentalis Pharmaceuticals Llc entry and exit signals to maximize returns.
| Accumulation Distribution | 27173.65 | |||
| Daily Balance Of Power | 0.15 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 2.39 | |||
| Day Typical Price | 2.4 | |||
| Price Action Indicator | 0.055 | |||
| Period Momentum Indicator | 0.03 |
Zentalis Pharmaceuticals Risk Indicators
The analysis of Zentalis Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Zentalis Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting zentalis stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 5.17 | |||
| Semi Deviation | 4.52 | |||
| Standard Deviation | 8.58 | |||
| Variance | 73.67 | |||
| Downside Variance | 28.81 | |||
| Semi Variance | 20.41 | |||
| Expected Short fall | (7.25) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Zentalis Pharmaceuticals
The number of cover stories for Zentalis Pharmaceuticals depends on current market conditions and Zentalis Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Zentalis Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Zentalis Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Zentalis Pharmaceuticals Short Properties
Zentalis Pharmaceuticals' future price predictability will typically decrease when Zentalis Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Zentalis Pharmaceuticals Llc often depends not only on the future outlook of the potential Zentalis Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Zentalis Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 71.1 M | |
| Cash And Short Term Investments | 371.1 M |
Check out Historical Fundamental Analysis of Zentalis Pharmaceuticals to cross-verify your projections. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zentalis Pharmaceuticals. Anticipated expansion of Zentalis directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Zentalis Pharmaceuticals assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of Zentalis Pharmaceuticals is measured differently than its book value, which is the value of Zentalis that is recorded on the company's balance sheet. Investors also form their own opinion of Zentalis Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Zentalis Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zentalis Pharmaceuticals' market value can be influenced by many factors that don't directly affect Zentalis Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zentalis Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zentalis Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Zentalis Pharmaceuticals' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.